{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:48:32Z","timestamp":1783475312351,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","painmanagementnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pain Management Nursing"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.pmn.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T15:39:05Z","timestamp":1683905945000},"page":"610-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["OnabotulinumtoxinA for Pediatric Migraine"],"prefix":"10.1016","volume":"24","author":[{"given":"Victoria","family":"Karian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb J.","family":"Schefter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-0043","authenticated-orcid":false,"given":"Allison","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Rogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-4700","authenticated-orcid":false,"given":"Brenna","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"LeBel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0001","first-page":"e343","article-title":"Further evidence that onabotulinum toxin is a viable treatment option for pediatric chronic migraine patients","volume":"11","author":"Ali","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.pmn.2023.04.006_bib0002","unstructured":"Allergan. (2021). BOTOX (onabotulinumtoxinA): Pescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/103000s5318lbl.pdf."},{"key":"10.1016\/j.pmn.2023.04.006_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.11.021","article-title":"A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices","volume":"54","author":"Andraka-Christou","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/20494637211014544","article-title":"The efficacy of botulinum toxin type-A for intractable chronic migraine patients with no pain-free time","volume":"16","author":"Atraszkiewicz","year":"2022","journal-title":"British Journal of Pain"},{"issue":"7","key":"10.1016\/j.pmn.2023.04.006_bib0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.pmn.2023.04.006_bib0006","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/rapm-2018-100196","article-title":"Response to BotulinumtoxinA in a migraine cohort with multiple comorbidities and widespread pain","volume":"44","author":"Barad","year":"2019","journal-title":"Regional Anesthesia & Pain Medicine"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/head.14024","article-title":"The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys","volume":"61","author":"Burch","year":"2021","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"7","key":"10.1016\/j.pmn.2023.04.006_bib0008","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of action of onabotulinumtoxinA in chronic migraine: A narrative review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"5","key":"10.1016\/j.pmn.2023.04.006_bib0009","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/JNN.0b013e3181aaa98f","article-title":"Botox treatment for migraine and chronic daily headache in adolescents","volume":"41","author":"Chan","year":"2009","journal-title":"Journal of Neuroscience Nursing"},{"issue":"10","key":"10.1016\/j.pmn.2023.04.006_bib0010","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/toxins4100913","article-title":"Clinical uses of botulinum neurotoxins: Current indications, limitations and future developments","volume":"4","author":"Chen","year":"2012","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-pharmtox-010818-021542","article-title":"The placebo effect in pain therapies","volume":"59","author":"Colloca","year":"2019","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pmn.2023.04.006_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.579047","article-title":"Migraine symptoms improvement during the COVID-19 lockdown in a cohort of children and adolescents","volume":"11","author":"Dallavalle","year":"2020","journal-title":"Frontiers in Neurology"},{"issue":"7","key":"10.1016\/j.pmn.2023.04.006_bib0013","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.pmn.2023.04.006_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jnnp.2007.134023","article-title":"Migraine prevention","volume":"7","author":"Dodick","year":"2007","journal-title":"Practical Neurology"},{"issue":"5","key":"10.1016\/j.pmn.2023.04.006_bib0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/a-1832-9168","article-title":"Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population","volume":"53","author":"Goenka","year":"2022","journal-title":"Neuropediatrics"},{"issue":"10","key":"10.1016\/j.pmn.2023.04.006_bib0016","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/head.12699","article-title":"Prevention for pediatric and adolescent migraine","volume":"55","author":"Hickman","year":"2015","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0017","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.24129","article-title":"Making decisions about stopping medicines for well-controlled juvenile idiopathic arthritis: A mixed-methods study of patients and caregivers","volume":"73","author":"Horton","year":"2021","journal-title":"Arthritis Care & Research"},{"issue":"4","key":"10.1016\/j.pmn.2023.04.006_bib0018","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/life12040536","article-title":"Emerging pharmacological treatments for migraine in the pediatric population","volume":"12","author":"Iannone","year":"2022","journal-title":"Life"},{"issue":"11","key":"10.1016\/j.pmn.2023.04.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241615","article-title":"Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system","volume":"15","author":"Javanbakht","year":"2020","journal-title":"PLos One"},{"issue":"2","key":"10.1016\/j.pmn.2023.04.006_bib0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11910-012-0251-1","article-title":"OnabotulinumtoxinA in pediatric chronic daily headache","volume":"12","author":"Kabbouche","year":"2012","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/j.pmn.2023.04.006_bib0021","series-title":"Getting ahead of pediatric headaches","first-page":"99","article-title":"External devices for headache","author":"Karian","year":"2020"},{"key":"10.1016\/j.pmn.2023.04.006_bib0022","series-title":"getting ahead of pediatric headaches","first-page":"72","article-title":"Preventive medications","author":"Karian","year":"2020"},{"issue":"6","key":"10.1016\/j.pmn.2023.04.006_bib0023","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/WNL.0000000000012261","article-title":"Factors associated with, and mitigation strategies for, health care disparities faced by patients with headache disorders","volume":"97","author":"Kiarashi","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0024","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s10194-018-0874-y","article-title":"OnabotulinumtoxinA in the treatment of refractory chronic cluster headache","volume":"19","author":"Lampl","year":"2018","journal-title":"Journal of Headache and Pain"},{"key":"10.1016\/j.pmn.2023.04.006_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpeds.2018.09.033","article-title":"Physical\u2013mental comorbidity of pediatric migraine in the Philadelphia neurodevelopmental cohort","volume":"205","author":"Lateef","year":"2019","journal-title":"Journal of Pediatrics"},{"issue":"9","key":"10.1016\/j.pmn.2023.04.006_bib0026","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/head.13639","article-title":"Economic impact of headache and psychiatric comorbidities on healthcare expenditures among children in the United States: A retrospective cross-sectional study","volume":"59","author":"Law","year":"2019","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"4","key":"10.1016\/j.pmn.2023.04.006_bib0027","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ijrobp.2018.12.019","article-title":"The insurance approval process for proton radiation therapy: A significant barrier to patient care","volume":"104","author":"Ning","year":"2019","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"11","key":"10.1016\/j.pmn.2023.04.006_bib0028","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0000000000008105","article-title":"Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"93","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.pmn.2023.04.006_bib0029","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40263-021-00834-9","article-title":"Indirect comparison of topiramate and monoclonal antibodies against CGRP or its receptor for the prophylaxis of episodic migraine: A systematic review with meta-analysis","volume":"35","author":"Overeem","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pmn.2023.04.006_bib0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fneur.2019.00771","article-title":"Prophylactic treatment of pediatric migraine: Is there anything new in the last decade?","volume":"10","author":"Papetti","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"11","key":"10.1016\/j.pmn.2023.04.006_bib0031","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bjae.2020.07.002","article-title":"Placebo effect in the management of chronic pain","volume":"20","author":"Perfitt","year":"2020","journal-title":"BJA Education"},{"issue":"2","key":"10.1016\/j.pmn.2023.04.006_bib0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1610384","article-title":"Trial of amitriptyline, topiramate, and placebo for pediatric migraine","volume":"376","author":"Powers","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.pmn.2023.04.006_bib0033","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp-2018-320113","article-title":"Non-invasive neuromodulation for migraine and cluster headache: A systematic review of clinical trials","volume":"90","author":"Reuter","year":"2019","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"2","key":"10.1016\/j.pmn.2023.04.006_bib0034","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5863\/1551-6776-26.2.151","article-title":"Experience of botulinum toxin A injections for chronic migraine headaches in a pediatric chronic pain clinic","volume":"26","author":"Santana","year":"2021","journal-title":"Journal of Pediatric Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1353\/pbm.1997.0032","article-title":"Botulinum toxin: The story of its development for the treatment of human disease","volume":"40","author":"Schantz","year":"1997","journal-title":"Perspectives in Biology and Medicine"},{"issue":"06","key":"10.1016\/j.pmn.2023.04.006_bib0036","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0032-1329612","article-title":"Ten-year follow-up in a case series of integrative botulinum toxin intervention in adolescents with chronic daily headache and associated muscle pain","volume":"43","author":"Schroeder","year":"2012","journal-title":"Neuropediatrics"},{"issue":"9","key":"10.1016\/j.pmn.2023.04.006_bib0037","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0883073818776142","article-title":"Onabotulinumtoxin A (BOTOX\u00ae) for prophylaCTIC treatment of pediatric migraine: A retrospective longitudinal analysis","volume":"33","author":"Shah","year":"2018","journal-title":"Journal of Child Neurology"},{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0038","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: A clinical and epidemiologic review","volume":"129","author":"Shapiro","year":"1998","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0039","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/maj.2002.121958","article-title":"Clinical results of botulinum toxin type a treatment of migraine headache","volume":"22","author":"Silberstein","year":"2002","journal-title":"Aesthetic Surgery Journal"},{"issue":"11","key":"10.1016\/j.pmn.2023.04.006_bib0040","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.pain.2014.08.036","article-title":"Pain and placebo in pediatrics: A comprehensive review of laboratory and clinical findings","volume":"155","author":"Simmons","year":"2014","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pmn.2023.04.006_bib0041","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ajad.12884","article-title":"Worries about discontinuing buprenorphine treatment: Scale development and clinical correlates","volume":"28","author":"Stein","year":"2019","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0042","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10194-008-0038-6","article-title":"Impact of headache in Europe: A review for the Eurolight project","volume":"9","author":"Stovner","year":"2008","journal-title":"The Journal of Headache and Pain"},{"issue":"10","key":"10.1016\/j.pmn.2023.04.006_bib0043","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/head.13414","article-title":"Recommendations on the use of Anti-CGRP monoclonal antibodies in children and adolescents","volume":"58","author":"Szperka","year":"2018","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0044","doi-asserted-by":"crossref","first-page":"037","DOI":"10.31083\/j.jin2101037","article-title":"OnabotulinumtoxinA for the treatment of headache: An updated review","volume":"21","author":"Talbet","year":"2022","journal-title":"Journal of Integrative Neuroscience"},{"issue":"6","key":"10.1016\/j.pmn.2023.04.006_bib0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.13091","article-title":"Migraine in children","volume":"57","author":"Tepper","year":"2017","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0046","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7861\/clinmedicine.4-3-258","article-title":"The story of Clostridium botulinum: From food poisoning to Botox","volume":"4","author":"Ting","year":"2004","journal-title":"Clinical Medicine"},{"issue":"7125","key":"10.1016\/j.pmn.2023.04.006_bib0047","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.316.7125.151c","article-title":"Clostridium botulinum was named because of association with \u201csausage poisoning","volume":"316","author":"Torrens","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.pmn.2023.04.006_bib0048","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpeds.2021.08.071","article-title":"Clinical interpretation of self-reported pain scores in children with acute pain","volume":"240","author":"Tsze","year":"2022","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"10.1016\/j.pmn.2023.04.006_bib0049","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamapediatrics.2020.5680","article-title":"Association of headache with school functioning among children and adolescents in the United States","volume":"175","author":"Turner","year":"2021","journal-title":"JAMA Pediatrics"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10194-021-01335-2","article-title":"CGRP monoclonal antibodies in migraine: An efficacy and tolerability comparison with standard prophylactic drugs","volume":"22","author":"Vandervorst","year":"2021","journal-title":"Journal of Headache and Pain"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0051","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s10194-018-0918-3","article-title":"Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment","volume":"19","author":"Vikelis","year":"2018","journal-title":"Journal of Headache and Pain"},{"issue":"7\u20138","key":"10.1016\/j.pmn.2023.04.006_bib0052","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1093\/milmed\/usy405","article-title":"Management of chronic migraine and occipital neuralgia in post 9\/11 combat veterans","volume":"184","author":"Williams","year":"2019","journal-title":"Military Medicine"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0053","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1129-2377-15-86","article-title":"The global burden of headache in children and adolescents \u2013 developing a questionnaire and methodology for a global study","volume":"15","author":"W\u00f6ber-Bing\u00f6l","year":"2014","journal-title":"Journal of Headache and Pain"},{"key":"10.1016\/j.pmn.2023.04.006_bib0054","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fped.2020.00028","article-title":"The efficacy and safety of topiramate in the prevention of pediatric migraine: An updated meta-analysis","volume":"8","author":"Wu","year":"2020","journal-title":"Frontiers in Pediatrics"},{"issue":"3","key":"10.1016\/j.pmn.2023.04.006_bib0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/head.12495","article-title":"Onabotulinum toxin A for the treatment of headache in service members with a history of mild traumatic brain injury: A cohort study","volume":"55","author":"Yerry","year":"2015","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.pmn.2023.04.006_bib0056","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13006-021-00438-5","article-title":"Fear of stopping\u201d vs \u201cwanting to get off the medication\u201d: Exploring women's experiences of using domperidone as a galactagogue - a qualitative study","volume":"16","author":"Zizzo","year":"2021","journal-title":"International Breastfeeding Journal"}],"container-title":["Pain Management Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904223000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904223000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:48:12Z","timestamp":1761500892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1524904223000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1524904223000917"],"URL":"https:\/\/doi.org\/10.1016\/j.pmn.2023.04.006","relation":{},"ISSN":["1524-9042"],"issn-type":[{"value":"1524-9042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OnabotulinumtoxinA for Pediatric Migraine","name":"articletitle","label":"Article Title"},{"value":"Pain Management Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmn.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}